Marshall Wace Portfolio holdings
AUM
$84.1B
This Quarter Return
+4.81%
1 Year Return
+27.54%
3 Year Return
+105.03%
5 Year Return
+179.94%
10 Year Return
+445.45%
AUM
$79.6B
AUM Growth
+$79.6B
(+3.4%)
Cap. Flow
+$1.33B
Cap. Flow
% of AUM
1.67%
Top 10 Holdings %
Top 10 Hldgs %
36.08%
Holding
2,970
New
646
Increased
882
Reduced
758
Closed
561
Top Buys
| 1 |
Apple
AAPL
|
$1.13B |
| 2 |
UnitedHealth
UNH
|
$832M |
| 3 |
Uber
UBER
|
$360M |
| 4 |
Boeing
BA
|
$352M |
| 5 |
Netflix
NFLX
|
$333M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$1.08B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$680M |
| 3 |
Meta Platforms (Facebook)
META
|
$642M |
| 4 |
Broadcom
AVGO
|
$452M |
| 5 |
GE Vernova
GEV
|
$439M |
Sector Composition
| 1 | Technology | 21.24% |
| 2 | Consumer Discretionary | 15.59% |
| 3 | Healthcare | 13.1% |
| 4 | Financials | 8.67% |
| 5 | Industrials | 6.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Jones Lang LaSalle
JLL
$14.2B
| $94.5M | 0.11% |
373,207
+214,087
| +135% | +$54.2M |
|
152
Costco
COST
$421B
| $94.4M | 0.11% |
103,077
+101,099
| +5,111% | +$92.6M |
|
153
Consolidated Edison
ED
$35.3B
| $94M | 0.11% |
1,053,339
+736,348
| +232% | +$65.7M |
|
154
Globus Medical
GMED
$7.94B
| $94M | 0.11% |
1,136,266
+486,756
| +75% | +$40.3M |
|
155
Wells Fargo
WFC
$258B
| $93.8M | 0.11% |
1,335,000
+917,103
| +219% | +$64.4M |
|
156
Amer Sports
AS
$21B
| $92.7M | 0.11% |
3,316,167
+2,401,302
| +262% | +$67.1M |
|
157
CAVA Group
CAVA
$7.64B
| $92.1M | 0.11% |
816,837
-1,127,114
| -58% | -$127M |
|
158
Cameco
CCJ
$33.6B
| $91.4M | 0.11% |
1,777,862
+359,794
| +25% | +$18.5M |
|
159
D.R. Horton
DHI
$51.3B
| $91.2M | 0.11% |
652,032
-1,119,600
| -63% | -$157M |
|
160
Southern Copper
SCCO
$82B
| $91M | 0.11% |
1,026,440
+336,193
| +49% | +$29.8M |
|
161
Regeneron Pharmaceuticals
REGN
$59.8B
| $90.8M | 0.11% |
127,400
-6,604
| -5% | -$4.7M |
|
162
Interactive Brokers
IBKR
$28.5B
| $90.4M | 0.11% |
2,046,544
-3,517,840
| -63% | -$155M |
|
|
ITCI
163
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $90.2M | 0.11% |
1,079,757
-81,216
| -7% | -$6.78M |
|
164
iShares TIPS Bond ETF
TIP
$13.5B
| $90.1M | 0.11% |
845,710
+306,340
| +57% | +$32.6M |
|
165
Garmin
GRMN
$45.6B
| $90M | 0.11% |
436,254
-626,211
| -59% | -$129M |
|
166
Alnylam Pharmaceuticals
ALNY
$58.6B
| $89.1M | 0.11% |
378,649
+315,182
| +497% | +$74.2M |
|
167
Keysight
KEYS
$28.4B
| $88.6M | 0.11% |
551,381
+233,461
| +73% | +$37.5M |
|
168
Goldman Sachs
GS
$221B
| $88.2M | 0.11% |
154,089
+145,166
| +1,627% | +$83.1M |
|
169
Clorox
CLX
$15B
| $88.1M | 0.11% |
542,726
+459,203
| +550% | +$74.6M |
|
170
Williams-Sonoma
WSM
$23.4B
| $87.1M | 0.1% |
+470,615
| New | +$87.1M |
|
171
Health Care Select Sector SPDR Fund
XLV
$33.8B
| $86.9M | 0.1% |
631,471
+142,550
| +29% | +$19.6M |
|
172
Arthur J. Gallagher & Co
AJG
$77.9B
| $86.8M | 0.1% |
305,920
+290,098
| +1,834% | +$82.3M |
|
173
Freeport-McMoran
FCX
$66.3B
| $86.1M | 0.1% |
2,261,536
-451,975
| -17% | -$17.2M |
|
174
Ventas
VTR
$30.7B
| $85.8M | 0.1% |
1,456,112
+1,364,504
| +1,490% | +$80.4M |
|
175
Idexx Laboratories
IDXX
$50.7B
| $85.6M | 0.1% |
207,114
+178,841
| +633% | +$73.9M |
|